tiprankstipranks
Trending News
More News >
Foghorn Therapeutics reports Q1 EPS (30c), consensus (29c)
PremiumThe FlyFoghorn Therapeutics reports Q1 EPS (30c), consensus (29c)
2M ago
Foghorn Therapeutics sees cash runway into 2027
Premium
The Fly
Foghorn Therapeutics sees cash runway into 2027
2M ago
Is FHTX a Buy, Before Earnings?
Premium
Pre-Earnings
Is FHTX a Buy, Before Earnings?
2M ago
Foghorn Therapeutics Presents Preclinical Data at AACR 2025
PremiumCompany AnnouncementsFoghorn Therapeutics Presents Preclinical Data at AACR 2025
2M ago
Foghorn Therapeutics initiated with an Outperform at Citizens JMP
Premium
The Fly
Foghorn Therapeutics initiated with an Outperform at Citizens JMP
2M ago
Promising Advancements and Strategic Collaborations Position Foghorn Therapeutics as a Strong Buy
Premium
Ratings
Promising Advancements and Strategic Collaborations Position Foghorn Therapeutics as a Strong Buy
4M ago
Analysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
PremiumStock Analysis & IdeasAnalysts Predict Up to ~450% Surge for These 2 ‘Strong Buy’ Penny Stocks
5M ago
Foghorn Therapeutics Advances Drug Development in Oncology
Premium
Company Announcements
Foghorn Therapeutics Advances Drug Development in Oncology
5M ago
Foghorn Therapeutics initiated with a Buy at B. Riley
Premium
The Fly
Foghorn Therapeutics initiated with a Buy at B. Riley
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100